Riordan Clinic IVC Academy teaches doctors about the use of high dose vitamin C

The Riordan Clinic is hosting its Second Riordan IVC Academy on March 13–14 at La Concha Resort in San Juan, Puerto Rico. The IVC Academy will introduce the concepts of high dose intravenous vitamin C (IVC) as an adjunctive clinical therapy. Medical professionals from around the world will attend the conference and take a collaborative look at the use of IVC therapy as a safe and effective adjunct to conventional approaches.

Thirty years ago, Dr Hugh Riordan treated his first cancer patient with high doses of intravenous vitamin C. The patient was a 70 year-old gentleman with kidney cancer and metastasis to the liver and lungs. Dr Riordan offered to treat this cancer patient palliatively with 30g of ascorbic acid (vitamin C) intravenously twice a week. After 15 months of therapy, the cancer was gone.

Some 70,000 vitamin C infusions later, Dr Riordan and his research team demonstrated scientific evidence to support the use of high dose ascorbate in the adjunctive care of cancer patients. Studies at the US National Institutes of Health have since replicated and advanced these findings.

Interest continues to grow through practitioners from around the world who have adopted the freely accessible 'Riordan IVC Protocol' for the administration of high dose IVC for the treatment of cancer, viral infections and other health concerns in a non-toxic fashion.

The Riordan Clinic hopes to continue this bold new initiative by hosting several IVC Academy's across the world during the next couple years. More information on the Riordan IVC Academy can be found here.

For more information about vitamin c research and the Riordan IVC Protocol, click here.